Background Rare de novo mutations have been implicated as a significant cause of
idiopathic intellectual disability. Large deletions encompassing 10p11. 23 have been …

OBJECTIVES: To describe the prevalence of multiple organ dysfunction syndrome (MODS)
and critical care utilization in children and young adults with acute myeloid leukemia (AML) …

Abstract Background High Risk (HR) or Very High Risk (VHR) acute lymphoblastic leukemia
(ALL) treated with 4 drug induction chemotherapy is often associated with adverse events …

Hyperleukocytosis in pediatric acute leukemia is associated with increased morbidity and
mortality and at present there is no consensus on the use of leukapheresis (LPH) for its …

Background Sinusoidal obstruction syndrome is a potentially fatal complication following
hematopoietic cell transplantation, high-intensity chemotherapies and increasingly seen …

Background: Understanding interventions preceding death in children with
immunocompromised conditions is important to ensure a peaceful and dignified perideath …

Hypogammaglobulinemia is a poorly described complication of chemotherapy in
adolescents and young adults (AYAs, 15–39 years) with acute lymphoblastic leukemia …

Myelodysplastic syndrome (MDS) is a rare pediatric diagnosis characterized by ineffective
hematopoiesis with potential to evolve into acute myelogenous leukemia (AML). In this …

Background The utility of bronchoscopy with bronchoalveolar lavage (BAL) in
immunocompromised children is not well understood. We aim to describe the bronchoscopy …

Background Hematopoietic stem cell transplantation (HSCT) is a common and effective
treatment for multiple malignant and non‐malignant pediatric conditions. Graft‐versus‐host …